Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,725,342
-
Share change
-
-157,266
-
Total reported value
-
$44,721,566
-
Price per share
-
$25.92
-
Number of holders
-
45
-
Value change
-
-$4,070,318
-
Number of buys
-
26
-
Number of sells
-
14
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q1 2014
As of 31 Mar 2014,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,725,342 shares.
The largest 10 holders included
Redmile Group, LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Advisors LLC, ROYCE & ASSOCIATES LLC, NORTHPOINTE CAPITAL LLC, WELLS FARGO & COMPANY/MN, BlackRock Institutional Trust Company, N.A., DAFNA Capital Management LLC, and MUTUAL OF AMERICA CAPITAL MANAGEMENT CORP.
This page lists
45
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.